Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    Keywords: APOPTOSIS ; CANCER ; tumor ; AGENTS ; Germany ; INHIBITION ; KINASE ; THERAPY ; POPULATION ; RISK ; PROTEIN ; DRUG ; DNA ; RISK-FACTORS ; INDUCTION ; BASE ; mechanisms ; protein kinase ; risk factors ; PROSTATE-CANCER ; chemotherapy ; PROTEIN-KINASES ; PROTEIN-KINASE-C ; pharmacokinetic ; PHARMACOKINETICS ; HUMAN TUMOR-CELLS ; antitumor agents ; Chinese herbal medicines ; BENZOPHENANTHRIDINE ALKALOIDS ; CANCER CELL-LINES ; CHELIDONIUM-MAJUS ; CITRUS FLAVONOIDS ; DNA TOPOISOMERASE-I ; ISODON DITERPENOIDS ; low molecular natural compounds ; MURINE HEPATOMA-CELLS ; traditional Chinese medicine
    Abstract: A series of low molecular compounds from Chinese herbal medicines which have proved to be, in some cases, highly effective especially in tumor therapy, is listed here (part II will deal with high molecular compounds, to be published in the next issue). In contrast to synthetic agents used in cancer chemotherapy, these natural compounds have relatively low toxicities. Many of the clinical studies referred to in this paper have been carried out on Asians. Because genetic factors influence enzyme levels, sometimes leading to striking differences in metabolism and pharmacokinetics of drugs, results obtained in clinical studies carried out in China are not 100% transferable to the European population. The mechanisms of action of these compounds are manifold, consisting of reactions with DNA bases, intercalation in DNA, inhibition of topoisomerases, inhibition of protein kinases, induction of apoptosis etc. Some of the compounds have interesting structural features, that may be used as lead structures for the development of further antitumor agents
    Type of Publication: Journal article published
    PubMed ID: 12677520
    Signatur Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...